SE0103210D0 - New formulations and use thereof - Google Patents

New formulations and use thereof

Info

Publication number
SE0103210D0
SE0103210D0 SE0103210A SE0103210A SE0103210D0 SE 0103210 D0 SE0103210 D0 SE 0103210D0 SE 0103210 A SE0103210 A SE 0103210A SE 0103210 A SE0103210 A SE 0103210A SE 0103210 D0 SE0103210 D0 SE 0103210D0
Authority
SE
Sweden
Prior art keywords
new formulations
compositions
nicotine
processes
manufacturing
Prior art date
Application number
SE0103210A
Other languages
English (en)
Swedish (sv)
Inventor
Thomas Landh
Nils-Olof Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0103210A priority Critical patent/SE0103210D0/xx
Publication of SE0103210D0 publication Critical patent/SE0103210D0/xx
Priority to BR0212834-9A priority patent/BR0212834A/pt
Priority to DE60232344T priority patent/DE60232344D1/de
Priority to ES02799531T priority patent/ES2325684T3/es
Priority to AT02799531T priority patent/ATE431144T1/de
Priority to IL16088602A priority patent/IL160886A0/xx
Priority to DK02799531T priority patent/DK1429770T3/da
Priority to EP02799531A priority patent/EP1429770B1/de
Priority to NZ532528A priority patent/NZ532528A/en
Priority to MXPA04002876A priority patent/MXPA04002876A/es
Priority to JP2003530292A priority patent/JP4262094B2/ja
Priority to PCT/SE2002/001612 priority patent/WO2003026656A1/en
Priority to CA002461757A priority patent/CA2461757C/en
Priority to CNA028190386A priority patent/CN1561213A/zh
Priority to AU2002334523A priority patent/AU2002334523B2/en
Priority to RU2004108853/15A priority patent/RU2282447C2/ru
Priority to KR10-2004-7004483A priority patent/KR20040047868A/ko
Priority to ARP020103631A priority patent/AR036679A1/es
Priority to ZA2004/02091A priority patent/ZA200402091B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0103210A 2001-09-27 2001-09-27 New formulations and use thereof SE0103210D0 (sv)

Priority Applications (19)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof
KR10-2004-7004483A KR20040047868A (ko) 2001-09-27 2002-09-10 신규한 제제 및 그의 용도
NZ532528A NZ532528A (en) 2001-09-27 2002-09-10 Nicotine-containing pharmaceutical composition comprising chocolate as a vehicle
JP2003530292A JP4262094B2 (ja) 2001-09-27 2002-09-10 新規製剤およびその使用
ES02799531T ES2325684T3 (es) 2001-09-27 2002-09-10 Nuevas formulaciones y uso de las mismas.
AT02799531T ATE431144T1 (de) 2001-09-27 2002-09-10 Neue formulierungen und ihre verwendung
IL16088602A IL160886A0 (en) 2001-09-27 2002-09-10 Nicotine containing pharmaceutical formulations and use thereof
DK02799531T DK1429770T3 (da) 2001-09-27 2002-09-10 Nye formuleringer og anvendelse deraf
EP02799531A EP1429770B1 (de) 2001-09-27 2002-09-10 Neue formulierungen und ihre verwendung
BR0212834-9A BR0212834A (pt) 2001-09-27 2002-09-10 Formulações e uso das mesmas
MXPA04002876A MXPA04002876A (es) 2001-09-27 2002-09-10 Nuevas formulaciones y uso de las mismas.
DE60232344T DE60232344D1 (de) 2001-09-27 2002-09-10 Neue formulierungen und ihre verwendung
PCT/SE2002/001612 WO2003026656A1 (en) 2001-09-27 2002-09-10 New formulations and use thereof
CA002461757A CA2461757C (en) 2001-09-27 2002-09-10 Nicotine formulations comprising chocolate and use thereof
CNA028190386A CN1561213A (zh) 2001-09-27 2002-09-10 新配方和其用途
AU2002334523A AU2002334523B2 (en) 2001-09-27 2002-09-10 New formulations and use thereof
RU2004108853/15A RU2282447C2 (ru) 2001-09-27 2002-09-10 Никотинсодержащая фармацевтическая композиция и ее применение
ARP020103631A AR036679A1 (es) 2001-09-27 2002-09-26 Formulaciones y uso de las mismas
ZA2004/02091A ZA200402091B (en) 2001-09-27 2004-03-16 New formulations and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof

Publications (1)

Publication Number Publication Date
SE0103210D0 true SE0103210D0 (sv) 2001-09-27

Family

ID=20285456

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof

Country Status (19)

Country Link
EP (1) EP1429770B1 (de)
JP (1) JP4262094B2 (de)
KR (1) KR20040047868A (de)
CN (1) CN1561213A (de)
AR (1) AR036679A1 (de)
AT (1) ATE431144T1 (de)
AU (1) AU2002334523B2 (de)
BR (1) BR0212834A (de)
CA (1) CA2461757C (de)
DE (1) DE60232344D1 (de)
DK (1) DK1429770T3 (de)
ES (1) ES2325684T3 (de)
IL (1) IL160886A0 (de)
MX (1) MXPA04002876A (de)
NZ (1) NZ532528A (de)
RU (1) RU2282447C2 (de)
SE (1) SE0103210D0 (de)
WO (1) WO2003026656A1 (de)
ZA (1) ZA200402091B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
RU2320674C1 (ru) * 2006-07-12 2008-03-27 Каш Тенгис Способ получения сополимера n-винилпирролидона с лаурилметакрилатом для трансдермального введения никотина, сополимер, полученный этим способом, гель для трансдермального введения никотина
CZ200980A3 (cs) * 2009-02-11 2010-04-28 Heglund A.S. Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
RU2453754C1 (ru) * 2010-12-27 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) Устройство для бестраншейной замены трубопроводов
RU2448573C1 (ru) * 2010-12-27 2012-04-27 Олег Иванович Квасенков Способ получения некурительного изделия из махорки

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
AR036679A1 (es) 2004-09-29
RU2282447C2 (ru) 2006-08-27
JP2005503429A (ja) 2005-02-03
AU2002334523B2 (en) 2007-02-15
ES2325684T3 (es) 2009-09-14
DK1429770T3 (da) 2009-08-03
ATE431144T1 (de) 2009-05-15
CA2461757C (en) 2008-09-02
KR20040047868A (ko) 2004-06-05
JP4262094B2 (ja) 2009-05-13
MXPA04002876A (es) 2005-06-20
CN1561213A (zh) 2005-01-05
NZ532528A (en) 2005-10-28
DE60232344D1 (de) 2009-06-25
BR0212834A (pt) 2004-10-13
WO2003026656A1 (en) 2003-04-03
EP1429770B1 (de) 2009-05-13
RU2004108853A (ru) 2005-04-20
IL160886A0 (en) 2004-08-31
CA2461757A1 (en) 2003-04-03
ZA200402091B (en) 2005-06-29
EP1429770A1 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
SE0103211D0 (sv) New formulations and use thereof
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
HUS1700003I1 (hu) Pirimidinamin-származékok és ezeket tartalmazó gyógyászati készítmények, mint angiogenézis modulátorok
TW200510416A (en) P38 inhibitors and methods of use thereof
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
DE60202477D1 (de) Vorrichtung zur verabreichung einer substanz
MXPA04005865A (es) Suministro de aminoglucosidos a los pulmones.
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
EE05074B1 (et) Sulfoonamiid- ja sulfamiidasendatud imidasokinoliinid, nende kasutamine raviks ja neid sisaldavad farmatseutilised preparaadid
MY143795A (en) Tetrahydropyridoindole derivatives
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
IL157656A (en) Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes
IL164108A (en) Quinoline derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of medicaments for the treatment of cns and other disorders
IL174154A (en) History of GLP-1 New Pharmaceutical Preparations Containing Them and Using It to Make Medicines
WO2005018605A3 (en) Novel formulation of ropinirole
DK1545537T3 (da) Alfa-7-nikotinreceptoragonister og statiner i kombination
MXPA05008478A (es) Heterociclos sustituidos.
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
IL179206A0 (en) Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same
MY134019A (en) Aryl oxime-piperazines useful as ccr5 antagonists
SE0200657D0 (sv) Novel Formulation
ATE353231T1 (de) Pharmazeutische zusammensetzungen
SE0300457D0 (sv) Novel compounds
CA2461757A1 (en) Nicotine formulations comprising chocolate and use thereof